The Journal of Neuropsychiatry and Clinical Neurosciences
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
J Neuropsychiatry Clin Neurosci 19:399-405, November 2007
doi: 10.1176/appi.neuropsych.19.4.399
© 2007 American Neuropsychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by Fiedorowicz, J. G.
* Articles by Robinson, R. G.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Fiedorowicz, J. G.
* Articles by Robinson, R. G.
Related Collections
* Depression
* Stroke

Risk Factors for and Correlates of Poststroke Depression Following Discontinuation of Antidepressants

Jess G. Fiedorowicz, M.D., M.S., Kenji Takezawa, M.D. and Robert G. Robinson, M.D.

Received February 17, 2006; revised October 14, 2007; accepted December 4, 2006. Drs. Fiedorowicz, Takezawa and Robinson are affiliated with the Department of Psychiatry, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, Iowa. Dr. Takezawa is also affiliated with the Department of Neuropsychiatry, Nippon Medical School, Tokyo, Japan. Address correspondence to Dr. Fiedorowicz, Department of Psychiatry, The University of Iowa Hospitals and Clinics, 500 Newton Rd., I-289 MEB, Iowa City, IA 52242; jess-fiedorowicz{at}uiowa.edu (e-mail).

The authors randomly assigned nondepressed patients at least 3 months poststroke to receive nortriptyline, fluoxetine, or placebo for 3 months using double-blind methodology. Patients were followed at 3, 6, 9, and 21 months for new onset of depression. In patients treated with antidepressants, lesion volume and degree of social impairment were associated with subsequent late-onset of poststroke depression at 6 and 9 months. In the placebo group, severity of impairment in activities of daily living, at 3 and 9 months, was associated with late onset poststroke depression. Differences in the clinical/pathological correlates may reflect subtle differences in the pathophysiology of poststroke depression following prophylactic antidepressants.







Get information about faster international access.

Privacy Policy

Copyright © 2007 American Neuropsychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Neuropsychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org